Clinical Trial Update: Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses [Phase 4]

View source ↗

Summary

Phase 4 trial assessing corneal disturbance (keratitis) associated with B+L Biotrue MPS used with B+L PureVision contact lenses; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratitis

Drugs mentioned

• B+L Biotrue MPS (Multi-Purpose Solution)
• PureVision lenses (Contact lenses)

Snippet

Sponsor: Epstein, Arthur B., OD, FAAO | Conditions: Keratitis | Phase 4 | Status: COMPLETED | Results posted: 2016-08-22